SII WRITES TO PMO ON REFORMS IN DRUG REGULATORY SYSTEM
06 Mar 2021 02:15 AM IST
The world’s largest vaccine production company, Serum Institute of India (SII), has written a letter to the PMO on reforms in the existing drug regulatory system, including allowing companies manufacturing and stockpiling of non-Covid vaccines while undergoing clinical trials. In the letter Prakash Kumar Singh, who is the Director of